Latest News for: gsk

Edit

GSK agrees $10 billion deal for Nuvalent cancer drugs

Chemistry World 16 Jun 2026
Deal includes two late-stage molecules to augment GSK’s renewed cancer therapy pipeline ....
Edit

Exdensur (depemokimab injection) approved in Canada for the treatment of severe asthma and chronic rhinosinusitis with nasal polyps (GSK - GlaxoSmithKline Inc)

Public Technologies 16 Jun 2026
MISSISSAUGA, ONTARIO - GSK announced today that Health Canada has approved Exdensur (depemokimab) for two indications ... Michelle Horn, VP & Country Medical Director, GSK Canada, said ... About GSK in Respiratory ... About GSK ... Find out more at www.gsk.ca.
Edit

Transaction in own shares (Form 6-K) (GSK plc)

Public Technologies 15 Jun 2026
GSK plc ... GSK plc (the "Company") announces today acting through Citigroup Global Markets Limited (the "Broker"), it has purchased the following number of the Company's ordinary shares of 31¼ pence each ... About GSK ... GSK enquiries.
Edit

Darby School Board selects parent, GSK worker to fill vacancy

Ravalli Republic 13 Jun 2026
The Darby School board voted unanimously to select parent Alexander Olson to fill vacancy on the board during their Monday evening meeting ... .
Edit

GSK's momelotinib granted Orphan Drug Designations in the US and EU for VEXAS syndrome (Form 6-K) (GSK plc)

Public Technologies 12 Jun 2026
GSK plc ... GSK's momelotinib granted Orphan Drug Designations in the US and EU for VEXAS syndrome ... GSK plc (LSE/NYSE ... About GSK. GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together.
Edit

Deerfield Management Announces Portfolio Company Nuvalent, Inc. to be Acquired by GSK

The Community Post 11 Jun 2026
... agreement to be acquired by GSK for $10.6 billion.
Edit

Slaughter and May is advising GSK on its $10.6bn acquisition of Nuvalent (Slaughter and May (Operations) Ltd)

Public Technologies 11 Jun 2026
Slaughter and May is advising GSK plc ("GSK") on the UK aspects and financing of its acquisition of Nuvalent, Inc ... GSK is a global biopharmaceutical company with a purpose to unite science, ...
Edit

Transaction notification (Form 6-K) (GSK plc)

Public Technologies 11 Jun 2026
GSK plc ... GSK plc (the 'Company') ... GSK plc ... GSK plc ... GSK plc ... GSK plc ... GSK plc ... GSK plc ... CEO, ViiV Healthcare and President, Global Health, GSK ... GSK plc ... GSK plc ... GSK plc ... About GSK ... Find out more at www.gsk.com ... GSK plc ... behalf of GSK plc.
Edit

The Franklin Institute and GSK Celebrate 40 Years of GSK Science in the Summer™ with ...

Caledonian Record 10 Jun 2026
National STEM Program Surpassed 400,000 Participants Since Founding in Philadelphia; expands to UK through partnership with OnSide ....
Edit

After shedding its cancer business just over a decade ago, GSK’s new CEO is building ...

Wall Street Journal 10 Jun 2026
After shedding its oncology business just over a decade ago, GSK is building it back with a $10.6 billion deal ... .
Edit

GSK to Acquire U.S. Biotech Firm Nuvalent for $10.6bn in Largest Pharma Deal in... (Tekedia Capital LLC)

Public Technologies 10 Jun 2026
) GSK has agreed to acquire U.S ... [...]. This is an abstract of the document ... Attachments Original document Permalink. Disclaimer ... (noodl. 132394770) .
Edit

The Franklin Institute and GSK Celebrate 40 Years of GSK Science in the Summer™ with New "Be A Chemist!" Theme and Program Expansion

PR Newswire 10 Jun 2026
Students in grades 2 through 6 will become cosmetic, forensic, materials, medicinal, and water chemists as part of GSK Science in the Summer™, a free hands-on STEM enrichment program led by The Franklin Institute and supported by GSK.
Edit

GSK Boosts Cancer Portfolio, Acquires Nuvalent for $10.6 Billion

This Day 10 Jun 2026
GSK shares slipped over 3 per cent in early trading in London ... “It’s larger than the bracket because it was unusual,” Miels told reporters on a call, although he said GSK’s sales targets were not dependent on the acquisition.
Edit

Tender Offer Statement (Form SC TO-C) (GSK plc)

Public Technologies 10 Jun 2026
... the SEC will also be available free of charge on GSK plc's website at https.//www.gsk.com/en-gb/investors or by contacting GSK plc's investor relations department at gsk.investor.relations@gsk.com.
Edit

GSK in talks to buy cancer biotech Nuvalent for more than $9bn

Financial Times 09 Jun 2026
A deal will rank as one of UK drugmaker’s biggest as biotech M&A activity accelerates this year ....

Article Search

tools
×
×
×
×